These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1700 related articles for article (PubMed ID: 28176481)

  • 1. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of antimicrobial peptide DP7 combined with antibiotics against multidrug-resistant bacteria.
    Wu X; Li Z; Li X; Tian Y; Fan Y; Yu C; Zhou B; Liu Y; Xiang R; Yang L
    Drug Des Devel Ther; 2017; 11():939-946. PubMed ID: 28356719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Pires J; Siriwardena TN; Stach M; Tinguely R; Kasraian S; Luzzaro F; Leib SL; Darbre T; Reymond JL; Endimiani A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7915-8. PubMed ID: 26459893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.
    van der Weide H; Vermeulen-de Jongh DMC; van der Meijden A; Boers SA; Kreft D; Ten Kate MT; Falciani C; Pini A; Strandh M; Bakker-Woudenberg IAJM; Hays JP; Goessens WHF
    Int J Antimicrob Agents; 2019 Aug; 54(2):159-166. PubMed ID: 31173867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR Study of the Secondary Structure and Biopharmaceutical Formulation of an Active Branched Antimicrobial Peptide.
    Castiglia F; Zevolini F; Riolo G; Brunetti J; De Lazzari A; Moretto A; Manetto G; Fragai M; Algotsson J; Evenäs J; Bracci L; Pini A; Falciani C
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31775296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa.
    Bluhm ME; Knappe D; Hoffmann R
    Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
    Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A; Neshani A; Mirhosseini SA; Ghazvini K; Zare H; Sedighian H
    Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
    Vidaillac C; Benichou L; Duval RE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining topology and sequence design for the discovery of potent antimicrobial peptide dendrimers against multidrug-resistant Pseudomonas aeruginosa.
    Stach M; Siriwardena TN; Köhler T; van Delden C; Darbre T; Reymond JL
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12827-31. PubMed ID: 25346278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria.
    Di Bonaventura I; Baeriswyl S; Capecchi A; Gan BH; Jin X; Siriwardena TN; He R; Köhler T; Pompilio A; Di Bonaventura G; van Delden C; Javor S; Reymond JL
    Chem Commun (Camb); 2018 May; 54(40):5130-5133. PubMed ID: 29717727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
    Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Mohamed MF; Brezden A; Mohammad H; Chmielewski J; Seleem MN
    Sci Rep; 2017 Jul; 7(1):6953. PubMed ID: 28761101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp.
    Goldberg JA; Kumar V; Spencer EJ; Hoyer D; Marshall SH; Hujer AM; Hujer KM; Bethel CR; Papp-Wallace KM; Perez F; Jacobs MR; van Duin D; Kreiswirth BN; van den Akker F; Plummer MS; Bonomo RA
    Eur J Med Chem; 2021 Aug; 220():113436. PubMed ID: 33933754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro synergistic effect of the CM11 antimicrobial peptide in combination with common antibiotics against clinical isolates of six species of multidrug-resistant pathogenic bacteria.
    Amani J; Barjini KA; Moghaddam MM; Asadi A
    Protein Pept Lett; 2015; 22(10):940-51. PubMed ID: 26216264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumon iae and P. aeruginosa.
    van der Weide H; Brunetti J; Pini A; Bracci L; Ambrosini C; Lupetti P; Paccagnini E; Gentile M; Bernini A; Niccolai N; Jongh DV; Bakker-Woudenberg IAJM; Goessens WHF; Hays JP; Falciani C
    Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1796-1804. PubMed ID: 28583831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
    Soren O; Brinch KS; Patel D; Liu Y; Liu A; Coates A; Hu Y
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6233-40. PubMed ID: 26248380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.